UIC
BIOX icon

Uniplan Investment Counsel’s Bioceres Crop Solutions BIOX Stock Holding History

Uniplan Investment Counsel’s Portfolio BIOX Stock Details BIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-226,925
Closed -$2.54M – 120
2024
Q2 		$2.54M Sell
226,925
-231,299
-50% -$2.7M 0.23% 94
2024
Q1 		$5.8M Sell
458,224
-1,139
-0.2% -$15K 0.46% 52
2023
Q4 		$6.31M Sell
459,363
-11,594
-2% -$136K 0.47% 50
2023
Q3 		$5.41M Buy
+470,957
New +$5.64M 0.41% 61
2023
Q2 		– Sell
-471,924
Closed -$5.48M – 119
2023
Q1 		$5.48M Buy
471,924
+40,584
+9% +$477K 0.39% 59
2022
Q4 		$5.19M Buy
431,340
+109,756
+34% +$1.42M 0.37% 62
2022
Q3 		$4.19M Buy
321,584
+34,497
+12% +$424K 0.32% 64
2022
Q2 		$3.94M Buy
287,087
+124,051
+76% +$1.65M 0.27% 73
2022
Q1 		$2.22M Buy
163,036
+80,006
+96% +$1.06M 0.13% 114
2021
Q4 		$1.17M Buy
+83,030
New +$1.15M 0.07% 128

Other funds holding BIOX

SP
Solel Partners Boston, Massachusetts $588M AUM 14.47% 1-Year Est. Return
FSC
Fourth Sail Capital Camana Bay Grand Cayman, Cayman Islands $660M AUM 27% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BAM
Ballast Asset Management Dallas, Texas $251M AUM 53.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Uniplan Investment Counsel's BIOX Position: Q3 2024 in Review

Uniplan Investment Counsel sold out of Bioceres Crop Solutions (BIOX) in Q3 2024, closing a stake of 226,925 shares — an estimated $2.54M sold.

Uniplan Investment Counsel first reported a position in BIOX in Q4 2021 and held it in 10 quarters. The position peaked at $6.31M in Q4 2023. 48 funds tracked by Wall St. Rank hold BIOX as of Q3 2024.

  • Uniplan Investment Counsel reported no remaining Bioceres Crop Solutions position as of Q3 2024 after selling out during the quarter.
  • Uniplan Investment Counsel sold 226,925 Bioceres Crop Solutions shares in Q3 2024, an estimated $2.54M.
  • Uniplan Investment Counsel first reported a position in Bioceres Crop Solutions in Q4 2021 and held it in 10 quarters.
  • Uniplan Investment Counsel's Bioceres Crop Solutions position peaked at $6.31M in Q4 2023.
  • 48 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q3 2024.

Based on Uniplan Investment Counsel's 13F filing for Q3 2024, filed 14 Nov 2024.